Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy

Moyes et al. validate approaches to engineer adult macrophages for payload delivery, establishing a platform with widespread utility. This is an effective proof point for functional derivation of similar macrophages derived from pluripotent stem cell sources. Read more.

Related News

Press Releases

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

May 26, 2021
Research Insights

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

June 27, 2019
Research Insights

Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

June 27, 2019
Press Releases

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

May 26, 2021
Research Insights

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

June 27, 2019
Research Insights

Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

June 27, 2019